Belgium· BE-AMP-SAM287454-00
M-M-RVaxPro
A masern, kombinationen mit mumps und röteln, lebend abgeschwächt product containing virus rubella, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Masern, kombinationen mit mumps und röteln, lebend abgeschwächt is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BD52 (masern, kombinationen mit mumps und röteln, lebend abgeschwächt), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Masern, kombinationen mit mumps und röteln, lebend abgeschwächt · ATC J07BD52
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Virus Rubella
- Manufacturer
- Merck Sharp & Dohme
- Country
- Belgium (BE)
- ATC code
- J07BD52
- ATC class
- Masern, Kombinationen mit Mumps und Röteln, lebend abgeschwächt
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BD52
Masern, kombinationen mit mumps und röteln, lebend abgeschwächt, as other registers publish it.
- CanadaM-M-R IIMERCK CANADA INC
- NorwayM-M-RvaxproMerck Sharp & Dohme B.V.
- DenmarkM-M-RvaxproMerck Sharp & Dohme B.V.
- DenmarkM-M-RvaxproMerck Sharp & Dohme B.V.
- FinlandM-M-RvaxproMerck Sharp & Dohme B.V.
- PolandM-M-RvaxProMerck Sharp & Dohme B.V.
- BelgiumM-M-RVaxProMerck Sharp & Dohme
- CzechiaM-M-RVAXPROMerck Sharp & Dohme B.V., Haarlem
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8d1fd4cd-ea6e-4a80-90c2-31095f19b211 GET /v1/drugs/8d1fd4cd-ea6e-4a80-90c2-31095f19b211?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for suspension for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "M-M-RVaxPro",
"name_fr": "M-M-RVaxPro",
"name_nl": "M-M-RVaxPro",
"amp_code": "SAM287454-00",
"strengths": [
"14.5000",
"14.5000"
],
"pack_count": 3,
"substances": [
"Virus Rubella",
"Mumps virus",
"Measles Virus",
"Monosodium Glutamate",
"Sodium Hydrogen Carbonate",
"Sodium Hydroxide",
"Sodium Phosphate",
"Sorbitol",
"Sucrose",
"Potassium Phosphate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Measles, Combinations with Mumps and Rubella, Live Attenuated",
"authorisation_numbers": [
"EU/1/06/337/001",
"EU/1/06/337/002",
"EU/1/06/337/014"
]
}See everything about masern, kombinationen mit mumps und röteln, lebend abgeschwächt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.